Form 4: BeiGene's Global Head of R&D, Lai Wang, Reports Stock Sales for Tax Obligations

Lai Wang, Global Head of R&D at BeiGene, Ltd., reports the sale of American Depositary Shares (ADS) to cover mandatory tax withholding obligations related to vesting restricted share units.

Summary

• On June 24, 2024, Lai Wang, the Global Head of R&D at BeiGene, Ltd., sold 2 American Depositary Shares (ADS) at $159.8 and 2 ADS at $161.1.
• These sales were executed to satisfy mandatory tax withholding requirements associated with the vesting of restricted share units.
• Following the reported transactions, Wang directly owns 1,724,697 ordinary shares and indirectly owns 58,188 ordinary shares through Wang Holdings LLC.
• Wang also has an indirect economic interest in RMB Shares held by the RMB Shares Employee Participation Plan, to which he contributed RMB10 million, but disclaims beneficial ownership of these shares except for his pecuniary interest.
• Each ADS represents 13 ordinary shares.

Sentiment

Score: 5

Explanation: This Form 4 filing is a routine disclosure of stock sales for tax purposes and doesn't indicate a positive or negative sentiment towards the company's prospects.

Industry Context

This filing is a routine disclosure related to insider transactions and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the company's outlook or performance.

Key Dates